By Anthony A. Hartmann, Finnegan, Henderson, Farabow, Garrett & Dunner LLP
The Leahy-Smith America Invents Act transformed the Board of Patent Appeals and Interferences into the Patent Trial and Appeal Board. The trial division of the PTAB is tasked with conducting AIA-created post-issuance trial proceedings: inter partes review, derivation proceedings, post grant review, and a transitional program for covered business methods.
These new trial proceedings feature limited discovery, such as mandatory initial disclosures, document production, affidavits, and depositions. With such discovery may come confidential information. Practitioners can reasonably anticipate situations when a petitioner or a patent owner will disclose information that is confidential to itself or others, or will seek discovery that is deemed confidential.
For example, both petitioner and patent owner owe a duty of candor and good faith, and must serve “relevant information that is inconsistent with a position advanced by the party during the proceeding….”1 The confidential information will likely be in the form of lab notebooks, test records, sales and marketing data, competitive product data, and pleadings from related proceedings. These types of documents are particularly relevant to issues addressed in the trial proceedings, such as swearing behind prior art, establishing inventorship, negating inferences of inherency with respect to the prior art, and weighing evidence of secondary indicia of nonobviousness.
Consequently, with the introduction of limited discovery, there is a need to address how to process and control confidential information during trial proceedings before the PTAB, just as with proceeding in federal court and the International Trade Commission. In apparent recognition of this, the AIA provided that:
The Director shall prescribe regulations … providing for protective orders governing the exchange and submission of confidential information.2
Last August, the Patent and Trademark Office issued Final Rules and an Office Patent Trial Practice Guide that included procedures for protecting confidential information in trial proceedings before the PTAB (157 PTD, 8/15/12). Consistent with Fed. R. Civ. P. 26(c)(1)(G), “confidential information” is defined as “trade secret or other confidential research, development, or commercial information.”3
Central to the protection of confidential information during a PTAB trial proceeding is Rule 42.54, 37 C.F.R. §42.54, governing both the exchange and submission of confidential information. According to this rule, when seeking to limit the scope of discovery, a party may file a motion for a protective order. When seeking to preclude public dissemination of a filing, a party may submit a motion to seal with a copy of a protective order.
Rule 42.54 gives the PTAB wide latitude to control the discovery and dissemination of confidential information, including by issuing sanctions. For example, upon a showing of good cause, the PTAB may deny discovery generally or with respect to certain matters, prescribe alternative methods for discovery, or limit discovery and/or its dissemination. Importantly, the terms of the proposed protective order, governing the treatment of confidential information that has been exchanged or submitted, take effect the moment the motion is filed until the PTAB modifies or lifts the protective order.4
Notably, the PTAB encourages the parties to negotiate a stipulated protective order to “govern the protection of confidential information contained in documents, discovery, or testimony adduced, exchanged, or filed with the board.”5 The Trial Practice Guide even provides a default protective order, as well as detailed guidance on the minimum contents of any proposed alternative protective order.6 Absent agreement among the parties, the default protective order will be automatically entered in the proceeding.7
Regardless, any proposed protective order must define what is deemed confidential information, who may see the confidential information, and how to exchange and serve the confidential information.8 The proposed protective order must also provide the means to be taken to protect the confidential information and an acknowledgement to be signed by all recipients of the confidential information.9 The PTAB has recently commented that, “For future reference, the Board requests that parties generally identify how a proposed protective order differs from the Board's default protective order.”10 Providing a red-line copy of the default protective order appears to be an appropriate mechanism.11
Even with this guidance, there are a multitude of issues that practitioners should consider when choosing between the default protective order and a more specialized protective order. The default protective order was not intended to be comprehensive. In fact, the office refused to include features that are common to protective orders because they address issues that were not expected to arise frequently in these contested proceedings, such as, for example, claw-back provisions and multiple tiers of confidentiality.12 Accordingly, practitioners should consider whether these are features relevant to their proceeding, particularly where they may be present in protective orders for related proceedings before the PTAB, another agency, or a federal court.
While the office is correct that many, if not most, proceedings will not need a complex protective order, there are several other considerations that practitioners should investigate when evaluating the form of the protective order:
In addition, consider whether party notification should be added to the protective order. Currently, there is no requirement to notify the opposing party as to who has signed the acknowledgement. This is particularly relevant to experts, who may need to be vetted further for conflicts. In that case, it would be practical to include a wait period after notification before the person can actually view confidential information.
This leads to the issue of a prosecution bar. The primary justification for a prosecution bar in district court and ITC protective orders is that the patent owner may prosecute claims to cover accused products. Yet, under PTAB trial procedures, the patent owner has the right to amend the claims once and it is lead counsel for the proceeding that will file the amendment. It is doubtful that the PTAB would accept a bar that limits the actions of lead counsel. Nonetheless, if there are related patent applications pending in the U.S. or abroad, a bar may be relevant.
However, while a patent-prosecution bar may resolve certain issues, it does not necessarily resolve the disclosure duties of the patent owner. If the petitioner proposes a prosecution bar, then the patent owner should propose a procedure whereby the patent owner may seek relief from the protective order restrictions in order to comply with the duty of disclosure.
The grant of the petition constitutes a grant of the motion to seal. If a petitioner is concerned whether the PTAB would grant the motion to seal, options are available. For example, the petitioner may file and serve a non-confidential petition and concurrently file a motion to supplement the petition, which is contingent upon the grant of a concurrently filed motion to seal. Hence, if the motion to seal is denied, no confidential information becomes available to the public or the patent owner.
Accordingly, under these circumstances, the patent owner cannot immediately access the sealed information, and possibly the entire petition, that has been filed against it. In order to access the confidential information of the petition prior to the institution of the trial proceeding, such as for the preliminary response, the patent owner must either agree to the terms of the proposed protective order, negotiate a new protective order with the petitioner, or a file a motion seeking entry of an alternative protective order, such as the default protective order.17 The office believes that since the patent owner has a three-month period to file its preliminary response, there should be sufficient time to file a motion seeking entry of a modified protective order, if needed.
Dealing with confidential information that had been exchanged is relatively simple. As with district court litigations, the protective order should be drafted to address whether and to what extent a party may maintain confidential information after the trial proceeding. If not, the Trial Practice Guide provides that, within one month after final termination of a proceeding, including all appeals, the parties will destroy all copies of received confidential information and provide certification of the destruction to each producing part.18
On the other hand, protecting the confidentiality of information submitted to the PTAB is not as simple. Despite the motions to seal and the associated protective orders, any provisions regarding post-trial protection do not control whether a party's confidential information that has been submitted to the PTAB may yet become public.
In keeping with the notice function of patents, public policy considerations favor creating and maintaining a clear record of the trial, particularly for later claim construction or other post-grant proceedings. The AIA provided that “The Director shall prescribe regulations … providing that the file of any proceeding under this chapter shall be made available to the public….”19 Indeed, the Trial Practice Guide explains:
There is an expectation that information will be made public where the existence of the information is referred to in a decision to grant or deny a request to institute a review or is identified in a final written decision following a trial. . . [Rule 42.56] balances the needs of the parties to submit confidential information with the public interest in maintaining a complete and understandable file history for public notice purposes.20
Not unexpectedly, the office rejected a proposal that the default position be that submitted information remain confidential.21 In fact, the PTAB presumes that confidential information will become public 45 days after final judgment or following denial of a petition. Accordingly, practitioners cannot assume that their granted motions to seal under Rule 42.14 will protect their secrets past final judgment. Rather, they should file motions to expunge the record under Rule 42.56.
Given the statutory and policy interests for a clear public record, however, there is certainly no guarantee that a motion to expunge will be granted. In fact, the office rejected a proposal that “petitions to expunge be granted in all but exceptional circumstances.”22 Since Rule 42.14 does not recite any standards for evaluating motions to expunge, the best predictor of how the PTAB will decide such motions is the Manual of Patent Examining Procedure.
While the MPEP does not address PTAB rules and procedures, Sections 724 to 724.06 of the MPEP provide procedures applying Rule 1.59.23 Rule 1.59 concerns petitions to expunge papers and information from pending patent applications and reexamination proceedings. While Rule 1.59, like Rule 42.56, is silent regarding the standard to evaluate the motion to expunge, MPEP §724.04 focuses on whether the information is deemed “material to patentability” when applying the rule. In practice, if the office relied upon the information in its determination of patentability, then the information is “material” and not expunged under Rule 1.59. If it was considered but not relied upon, the information is not “material” and expunged. This is consistent with the above-discussed policy for Rule 42.56.
Notably, in the context of Rule 1.59, the office distinguishes information that is “favorable to patentability,” such as evidence of commercial success, from information that is “material to patentability.”24 Specifically, the office has found that since there is a duty to disclose information “material to patentability,” only that class of confidential information is covered by Rule 1.59 petitions to expunge. Confidential information that is “favorable to patentability” is not covered and, therefore, cannot be expunged.
Whether or not this same analysis will be applied to a Rule 42.56 motion to expunge remains to be seen. However, given that there is a duty of candor and good faith in these post-issuance trial proceedings (Rule 42.11) and, at least in the context of patent prosecution (Rule 1.56) and reexamination (Rule 1.555), this duty has been defined to “include a duty to disclose to the Patent Office all information known to that individual to be material to patentability… ,” there is currently a risk that Rule 42.56 motions to expunge may not be granted with respect to confidential information related to secondary indicia of nonobviousness.
If a petition to expunge is denied, another course of action may be available to practitioners to protect the confidential information. As with patent prosecution and reexamination proceedings, it may be possible to file a motion to substitute a redacted version of the confidential document.25 Of course, the redacted information would likely need to be incidental or unrelated to the information that the PTAB found necessary for its decision. Chances are good that such a motion would be considered, particularly since the office “encourages parties to redact sensitive information, where possible, rather than seeking to seal entire documents.”26
©2014 The Bureau of National Affairs, Inc. All rights reserved. Bloomberg Law Reports ® is a registered trademark and service mark of The Bureau of National Affairs, Inc.
This document and any discussions set forth herein are for informational purposes only, and should not be construed as legal advice, which has to be addressed to particular facts and circumstances involved in any given situation. Review or use of the document and any discussions does not create an attorney-client relationship with the author or publisher. To the extent that this document may contain suggested provisions, they will require modification to suit a particular transaction, jurisdiction or situation. Please consult with an attorney with the appropriate level of experience if you have any questions. Any tax information contained in the document or discussions is not intended to be used, and cannot be used, for purposes of avoiding penalties imposed under the United States Internal Revenue Code. Any opinions expressed are those of the author. The Bureau of National Affairs, Inc. and its affiliated entities do not take responsibility for the content in this document or discussions and do not make any representation or warranty as to their completeness or accuracy.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)